Novartis' T-cell therapy for blood cancer, developed with Penn, wins European approval https://t.co/BEgFdymcKb
— Marisa Peer (@PeerMarisa) August 27, 2018
from Twitter https://twitter.com/PeerMarisa
August 27, 2018 at 07:21AM
Monday, August 27, 2018
Novartis' T-cell therapy for blood cancer, developed with Penn, wins European approval https://t.co/BEgFdymcKb
from Twitter https://twitter.com/PeerMarisa
August 27, 2018 at 07:21AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment